Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cristina Marcos-Fosch"'
Autor:
Lara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, Raúl Felipe Palma-Alvarez, Ariadna Rando-Segura, Jordi Llaneras, Marta Perea-Ortueta, Francisco Rodriguez-Frias, Nieves Martínez-Luna, Mar Riveiro-Barciela, Josep Antoni Ramos-Quiroga, Joan Colom, Rafael Esteban, María Buti
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Hepatitis C virus (HCV) management is a challenge in patients with substance use disorder (SUD). This study aimed to describe an HCV screening and linkage to care program in SUD patients, and analyze the characteristics of this population
Externí odkaz:
https://doaj.org/article/ef43e1ce8b5c4d57abebc3214ced198c
Autor:
Beatriz Mateos-Muñoz, María Buti, Inmaculada Fernández Vázquez, Marta Hernández Conde, Vanesa Bernal-Monterde, Fernando Díaz-Fontenla, Rosa María Morillas, Luisa García-Buey, Ester Badía, Mireia Miquel, Alberto Amador-Navarrete, Sergio Rodríguez-Tajes, Lucía Ramos-Merino, Antonio Madejón, Montserrat García-Retortillo, Juan Ignacio Arenas, Joaquín Cabezas, Jesús Manuel González Santiago, Conrado Fernández-Rodríguez, Patricia Cordero, Moisés Diago, Antonio Mancebo, Alberto Pardo, Manuel Rodríguez, Elena Hoyas, Jose Javier Moreno, Juan Turnes, Miguel Ángel Simón, Cristina Marcos-Fosch, Jose Luis Calleja, Rafael Bañares, Sabela Lens, Javier Garcia-Samaniego, Javier Crespo, Manuel Romero-Gomez, Francisco Gea, Enrique Rodríguez de Santiago, Santiago Moreno, Agustin Albillos
Publikováno v:
Scientia
COVID-19; Hepatitis B; Tenofovir COVID-19; Hepatitis B; Tenofovir COVID-19; Hepatitis B; Tenofovir Background and Aims HIV-positive patients on tenofovir hydroxyl fumarate (TDF)/emtricitabine have a lower risk of COVID-19 and hospitalization than tho
Autor:
Anthony Nardone, Lina Nerlander, Erika Duffell, Marta Valenciano, Maria Buti, Cristina Marcos-Fosch, Tatjana Nemeth-Blažić, Odette Popovici, Adriana Vince, Petruta Violeta Filip, Tajana Filipec, Mirjana Lana Kosanović Ličina, Boris Luksic, Diana Nonković, Corina Silvia Pop, Fabiana Radu, Irina Teodorescu, Adriana Violeta Topan
Publikováno v:
Scientia
Background The World Health Organization European Action Plan 2020 targets for the elimination of viral hepatitis are that > 75% of eligible individuals with chronic hepatitis B (HBV) or hepatitis C (HCV) are treated, of whom > 90% achieve viral supp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe1f344f67eb9c791494b7d8b676c66
https://hdl.handle.net/11351/9162
https://hdl.handle.net/11351/9162
Autor:
Antonio Craxì, Isidro Sanz-Pérez, Mar Riveiro-Barciela, Rafael Esteban, Fernando Martínez-Valle, María-Teresa Salcedo, Fabrizio Bronte, Daniele Torres, Maria Buti, Cristina Marcos-Fosch, Salvatore Petta, Olimpia Orozco
Publikováno v:
World Journal of Gastroenterology
BACKGROUND There is an increased risk of atherosclerosis in patients with chronic hepatitis C or human immunodeficiency virus, but there is scarce data on hepatitis B virus infection. The hypothesis of this study is that hepatitis B virus infection i
Autor:
Cristina Marcos-Fosch, Luisa Roade, Rafael Esteban, Maria Buti, Fernando Velázquez, Francisco Rodriguez-Frias, Mar Riveiro-Barciela, J. Llaneras, Ariadna Rando-Segura
Publikováno v:
Clinical Gastroenterology and Hepatology. 19:1030-1037
Background and Aim Etiologies of acute viral hepatitis in high-income countries change with migration of populations, lifestyle changes, and emergence of new pathogens. We analyzed etiologies, characteristics, and outcomes of patients with acute vira
Autor:
Raúl Felipe Palma-Álvarez, Josep Antoni Ramos-Quiroga, Joan Colom, Constanza Daigre, Mar Riveiro-Barciela, Rafael Esteban, Marta Perea-Ortueta, Nieves Martínez-Luna, J. Llaneras, Ariadna Rando-Segura, Cristina Marcos-Fosch, Lara Grau-López, Francisco Rodriguez-Frias, Maria Buti
Publikováno v:
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Scientia
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Scientia
Background: Hepatitis C virus (HCV) management is a challenge in patients with substance use disorder (SUD). This study aimed to describe an HCV screening and linkage to care program in SUD patients, and analyze the characteristics of this population
Publikováno v:
Journal of hepatology. 75(4)
Publikováno v:
Liver international : official journal of the International Association for the Study of the LiverREFERENCES. 41
Chronic hepatitis B virus (HBV) infection remains an important global health problem, and may be difficult to manage in clinical practice. Nucleos(t)ide analogues (NAs) with a high barrier to resistance (entecavir [ETV], tenofovir disoproxil fumarate
Publikováno v:
American Journal of Therapeutics. 25:e601-e602
Autor:
Maria Homs, I. Sanz-Perez, R. Esteban, M. Buti, Mar Riveiro-Barciela, Fernando Martínez-Valle, Cristina Marcos-Fosch, Francisco Rodriguez-Frias, David Tabernero
Publikováno v:
Journal of Hepatology. 64:S368